General anaesthesia in elderly patients with cardiovascular disorders: Choice of anaesthetic agent

Drugs and Aging

Volumn 27, Issue 4, 2010, Pages 265-282

  Das, Sangeeta ^a   Forrest, Kirsty ^a   Howell, Simon ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ANESTHETIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRACURIUM BESILATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DESFLURANE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ETOMIDATE; FENTANYL; FUROSEMIDE; ISOFLURANE; KETAMINE; MIDAZOLAM; MORPHINE; NEOSTIGMINE; OPIATE; PANCURONIUM BROMIDE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX; SUXAMETHONIUM; THIAZIDE DIURETIC AGENT; THIOPENTAL; UNINDEXED DRUG; VECURONIUM;

AGED; AGING; ANESTHESIA INDUCTION; ARTERIAL STIFFNESS; ASYSTOLE; BLOOD PRESSURE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL TRIAL; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DELIRIUM; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG PREFERENCE; DRUG SAFETY; EEG ABNORMALITY; GENERAL ANESTHESIA; GERIATRIC PATIENT; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART BLOCK; HEART FAILURE; HEART OUTPUT; HEART RATE; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMMUNE DEFICIENCY; INHALATION ANESTHESIA; INJECTION PAIN; INTRAVENOUS ANESTHESIA; ISCHEMIA; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; LUNG ARTERY PRESSURE; MYOCLONUS; NAUSEA AND VOMITING; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; SINUS ARREST; SURGICAL PATIENT; SURGICAL RISK; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; VALVULAR HEART DISEASE;

AGED; AGED, 80 AND OVER; AGING; ANALGESICS, OPIOID; ANESTHESIA, GENERAL; ANESTHETICS; CARDIOVASCULAR DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEUROMUSCULAR AGENTS;

EID: 77950640353     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11534990-000000000-00000     Document Type: Review

References (132)

1. Priebe HJ. The aged cardiovascular risk patient. Br J Anaesth 2000; 85: 763-778
2. Friedl LP, Kronmal RA, Newman AB, et al. Risk factors for five year mortality in older adults: the Cardiovascular Health Study. JAMA 1998; 279: 585-592
3. Hall WJ. Update in geriatrics. Ann Intern Med 1997; 127: 557-564
4. Shipton EA. The perioperative care of the geriatric patient. S Afr Med J 1983; 63: 855-860
5. Help the aged: we will. Facts and figures [online]. Available from URL: http://www.helptheaged.org.uk/en-gb/What WeDo/FactsAndFigures/FactsAndFigures/ [Accessed 2009 Feb 1]
6. Rooke GA. Cardiovascular ageing and anesthetic implications. J Cardiothorac Vasc Anesth 2003; 17 (4): 512-523
7. Lichtor JL. Sponsored research reveals postoperative mortality stats. Anesth Patient Saf Found Newsl 1988; 3: 9-11
8. Khuri SF, Daley J, Henderson W, et al. Risk adjustment of postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg 1997; 185: 315-327
9. Groenink M, Langerak SE, Vanbavel E, et al. The influence of ageing and aortic stiffness on permanent dilation and breaking stress of the thoracic descending aorta. Cardiovasc Res 1999; 43: 471-480
10. Lakatta E. Ageing effects on the vasculature in health: risk factors for cardiovascular disease. Am J Geriatr Cardiol 1994; 3: 11-17
11. Lakatta EG. Cardiovascular ageing research: the next horizons. J Am Geriatr Soc 1999; 47: 613-625
12. Bulpitt CJ, Rajkumar C, Cameron JD. Vascular compliance as a measure of biological age. J Am Geriatr Soc 1999; 47: 657-663
13. Yin FCP, Ting CT. Compliance changes in physiological and pathological states. J Hypertension 1992; 10 Suppl.: 31-33
14. Downes TR, Nomeir AB, Smith KM, et al. Mechanism of altered pattern of left ventricular filling with ageing in subjects without cardiac disease. Am J Cardiol 1989; 64: 523-527
15. Ebert TJ,Morgan BJ, Barney JA, et al. Effects of ageing on baroreflex regulation of sympathetic activity in humans. Am J Physiol 1992; 263: H798-803
16. Lakatta EG. Alteration in the cardiovascular system that occur in advanced age. Fed Proc 1979; 38: 13-167
17. Fagard R, Thijs L, Amery A. Age and the hemodynamic response to posture and to exercise. Am J Geriatr Cardiol 1993; 2: 23-40
18. Gribbin B, Pickering TG, Sleight P, et al. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res 1971; 29: 424-431
19. Critchley LAH, Conway F. Hypotension during subarachnoid anaesthesia: haemodynamic effects of colloid and metaraminol. Br J Anaesth 1996; 76: 734-736
20. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. Executive summary: report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2007; 50: 1707-1732
21. Shah KB, Kleinman BS, Sami H, et al. Re-evaluation of perioperative myocardial infarction in patients with prior myocardial infarction undergoing noncardiac operations. Anesth Analg 1990; 71: 231-235
22. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297: 845-850
23. Howell SJ, Sear YM, Sear JW, et al. Cardiovascular death within 30 days following anaesthesia and urgent or emergency surgery: determination of risk factors using a nested case control study. Br J Anaesth 1999; 82: 679-684
24. Levine WC, Mehta V, Landesberg G, et al. Anaesthesia for elderly: selected topics. Curr Opin Anaesthesiol 2006; 19: 320-324
25. Hart CY, Redfield MM. Diastolic heart failure in the community. Curr Cardiol Rep 2000; 2: 461-469
26. Howell SJ, Sear JW, Foex P. Hypertension, hypertensive heart disease and perioperative cardiac risk. Br J Anaesth 2004; 92 (4): 570-583
27. Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999; 100: 354-360
28. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV). BMJ 2004; 328: 634-640 (Pubitemid 38340037)
29. Aronson S, Boisvert D, Lapp W. Isolated systolic hypertension is associated with adverse outcomes from coronary artery bypass grafting surgery. Anesth Analg 2002; 94: 1079-1084
30. Podrid PJ. Atrial fibrillation in the elderly. Cardiol Clin 1999; 17: 173-188
31. Christ M, Sharkova Y, Geldner G, et al. Preoperative and perioperative care for patients with suspected or established aortic stenosis facing noncardiac surgery. Chest 2005; 128: 2944-2953
32. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease: Cardiovascular Health Study. J Am Coll Cardiol 1997; 29: 630-634
33. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993; 21: 1220-1225
34. Lombard JT, Selzer A. Valvular aortic stenosis: a clinical and hemodynamic profile of patients. Ann Intern Med 1987; 106: 292-298
35. Eagle KA, Berger PB, CalkinsH, et al.ACC/AHAguideline update for perioperative cardiovascular evaluation for noncardiac surgery. Executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Anesth Analg 2002; 94: 1052-1064
36. Cooper N, Forrest K, Mulley G, editors. ABC of geriatric medicine. Oxford: Wiley-Blackwell, 2009 Jan
37. Comfere T, Sprung J, Kumar MM, et al. Angiotensin system inhibitors in a general surgical population. Anesth Analg 2005; 100: 636-644
38. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery: Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996; 335: 1713-1720
39. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery: Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341: 1789-1794
40. POISE study group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-1847
41. Poldermans D, Schouten O, Van Lier F, et al. Perioperative strokes and b-blockade. Anesthesiology 2009; 111: 940-945
42. Hayashi Y, Sumikawa K, Kuro M, et al. Rolls of beta 1 and beta 2 adrenoceptors in the mechanism of halothane myocardial sensitization in dogs. Anesth Analg 1991; 72 (4): 435-439
43. WoodM. Pharmacokinetic drug interactions in anaesthetic practice. Clin Pharmacokinet 1991; 21 (4): 285-304
44. Wali FA. Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium. Eur J Anaesthesiol 1986; 3 (5): 385-393
45. Dec GW. Digoxin remains useful in the treatment of chronic heart failure. Med Clin North Am 2003; 87 (2): 317-337
46. Bartolone RS, Rao TL. Dysrhythmias following muscle relaxant administration in patients receiving digitalis. Anesthesiology 1983; 58 (6): 567-569
47. Stoelting RK. Pharmacology and physiology in anesthetic practice. 3rd ed. Philadelphia (PA): Lippincott-Raven, 1999
48. Silverstein JH, Rooke GA, Reves JG, et al. Geriatric anaesthesiology. 2nd ed. New York: Springer Science and Business Media, 2008
49. Martin G, Glass PS, Breslin DS, et al. A study of anesthetic drug utilisation in different age groups. J Clin Anesth 2003; 15 (3); 194-200
50. Kirkbride DA, Parker JL,Williams GD, et al. Induction of anesthesia in the elderly ambulatory patients: a double blinded comparison of propofol and sevoflurane. Anesth Analg 2001; 93 (5): 1185-1187
51. John AD, Sieber FE. Age associated issues: geriatrics. Anesthesiol Clin North Am 2004; 22 (1): 45-58
52. Shafer SL. The pharmacology of anaesthetic drugs in elderly patients. Anesthesiol Clin North Am 2000; 18 (1): 1-29
53. Scheepstra GL, Booij LH, Rutten CL, et al. Propofol for induction and maintenance of anaesthesia: comparison between older and younger patients. Br J Anaesth 1989; 62: 54-60
54. Kazama T, Ikeda K, Morita K, et al. Comparison of the effect site k(e0)s of propofol for blood pressure and EEG by spectral index in elderly and younger patients. Anesthesiology 1999; 90 (6): 1517-1527
55. Schuttler J, Ihmsen H. Population pharmacokinetics of propofol: a multicenter study. Anesthesiology 2000; 92: 727-738
56. Schnider TW, Minto CF, Gumbus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88 (5): 1170-1182
57. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502-1516
58. Russo H, Bressolle E. Pharmacokinetics and pharmacodynamics of thiopental. Clin Pharmacokinet 1998; 35: 95-134
59. The history of intravenous anaesthesia: the barbiturates. Part 1. Anaesth Intensive Care 2001; 29 (2): 97
60. Ball C, Westhorpe R. The history of intravenous anaesthesia: the barbiturates. Part 2. Anaesth Intensive Care 2001; 29 (3): 219
61. Ball C, Westhorpe R. The history of intravenous anaesthesia: the barbiturates. Part 3. Anaesth Intensive Care 2001; 29 (4): 323
62. Dundee JW. Fifty years of thiopentone [editorial]. Br J Anaesth 1984; 56: 211
63. Sonntag H, Hellberg K, Schenk HD, et al. Effects of thiopental (Trapanal) on coronary blood flow and myocardial metabolism in man. Acta Anesthesiol Scand 1975; 19 (1): 69-78
64. Homer TD, Stanski DR. The effect of increasing age on thiopental disposition and anesthetic requirement. Anesthesiology 1985; 62: 714-724
65. Stanski DR, Maitre PO. Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited. Anesthesiology 1990; 72: 412-422
66. Dundee JW, Halliday NJ, Loughran PG, et al. The influence of age on the onset of anaesthesia with midazolam. Anaesthesia 1985; 40: 441-443
67. White PF, Negus JB. Sedative infusions during local and regional anesthesia: a comparison of midazolam and propofol. J Clin Anesth 1991; 3 (1): 32-39
68. Sunzel M, Pallzow L, Berggren L, et al. Respiratory and cardiovascular effects in relation to plasma levels of midazolam and diazepam. Br J Clin Pharmacol 1988; 25: 561-569
69. Samuelson PN, Reves JG, Kouchoukos NT, et al. Hemodynamic responses to anesthetic induction with midazolam or diazepam in patients with ischemic disease. Anesth Analg 1981; 60: 802-809
70. Rouff R, Reves JG. Hemodynamic effects of lorazepamfentanyl anesthetic induction for coronary artery bypass surgery. J Cardiothorac Anesth 1990; 4: 314-317
71. Heikkilä H, Jalonen J, Arola M, et al. Midazolam as adjunct to high-dose fentanyl anesthesia for coronary artery bypass graft operation. Acta Anaesthesiol Scand 1984; 28: 683-689
72. Benson KT, Tomlinson DL, Goto H, et al. Cardiovascular effects of lorazepam during sufentanil anesthesia. Anesth Analg 1988; 67: 966-968
73. Windsor JW, Sherry K, Feneck RO, et al. Sufentanil and nitrous oxide anesthesia for cardiac surgery. Br J Anaesth 1988; 61: 662-668
74. Maitre PO, Buhrer M, Thomson D, et al. A three-step approach combining Bayesian regression and NONMEM population analysis: application to midazolam. J Pharmacokinet Biopharm 1991; 19: 377-384
75. Reves JG, Fragen RJ, Vinik HR, et al. Midazolam: pharmacology and uses. Anesthesiology 1985; 62: 310-324
76. Allolio B, Dorr H, Stuttmann R, et al. Effect of a single bolus dose of etomidate upon eight major corticosteroid hormones and plasma ACTH. Clin Endocrinol (Oxf) 1985; 22: 281-286
77. Holdcroft A, Morgan M, Whitwam JG, et al. Effect of dose and premedication on induction complications with etomidate. Br J Anaesth 1976; 48: 199-205
78. Kettler D, Sonnata H, Donath U, et al. Haemodynamics, myocardial mechanics, oxygen requirement and oxygenation of the human heart during induction of anaesthesia with etomidate [in German]. Anaesthesist 1974; 23: 116-121
79. Arden JR, Holley OF, Stanski DR. Increased sensitivity to etomidate in the elderly: initial distribution versus altered brain response. Anesthesiology 1986; 65: 19-27
80. Calvey TN, Williams NE. Principles and practice of pharmacology for anaesthetists. 4th ed. Oxford: Blackwell Scientific Publications, 2001
81. Jolly AS, Jain P, Sood J. Ketamine: current uses and future perspectives. J Anaesthesiol Clin Pharmacol 2007; 23 (2): 169-181
82. Granry JC, Dube L, Turroques H, et al. Ketamine: new uses for an old drug. Curr Opin Anaesthesiol 2000; 13 (3): 299-302
83. Finlay I. Ketamine and its role in cancer pain. Pain Rev 1999; 6 (4): 303-313
84. Maneglia R, Cousin MT. A comparison between propofol and ketamine for anaesthesia in the elderly: haemodynamic effects during induction and maintenance. Anaesthesia 1988; 43 Suppl.: 109-111
85. Zickmann B, Kling D, Quis S. S-(+)-ketamine versus ketamine racemic mixture: hemodynamic studies. Anasthesiol Intensivmed Notfallmed Schmerzther 2000; 35 (5): 333-339
86. Adams HA. S-(+)-ketamine: cardiovascular interactions during total intravenous anaesthesia and analgosedation. Anaesthesist 1997; 46 (12): 1081-1087
87. PaiA,HeiningM.Ketamine. Cont Educ Anaesth Crit Care Pain (CEACCP) 2007; 7: 59-63
88. Miller RD. Miller's anesthesia. 7th ed. Edinburgh: Elsevier Churchill Livingstone, 2009
89. Hudetz JA, Iqbal Z, Gandhi SD, et al. Ketamine attenuates post-operative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand 2009; 53 (7): 864-872
90. Himmelseher S, Pfenninger E. The clinical use of S-(+)- ketamine: a determination of its place. Anasthesiol Intensivmed Notfallmed Schmerzther 1998; 33 (12): 764-770
91. Houltz E, Caidahl K, Adin C, et al. Effects of halothane and isoflurane on left ventricular diastolic function during surgical stress in patients with coronary artery disease. Acta Anaesthesiol Scand 1996; 41: 931-938
92. McKinney MS, Fee JP, Clarke RS. Cardiovascular effects of isoflurane and halothane in young and elderly patients. Br J Anaesth 1993; 71: 696-701
93. Malan TP, Dinardo JA, Isner RJ, et al. Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers. Anesthesiology 1995; 83: 918-928
94. Yamaguchi S, Ikeda T, Wake K, et al. A sevoflurane induction of anaesthesia with gradual reduction of concentration is well tolerated in elderly patients. Can J Anesth 2003; 50: 26-31
95. Weiskopef RB, Moore MA, Eger II EI, et al. Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans. Anesthesiology 1994; 80: 1035-1045
96. Mapleson WW. Effect of age on MAC in humans: a metaanalysis. Br J Anaesth 1996; 76: 179-185
97. Cepeda MS, Farrar JT, Baumgarten M, et al. Side effects of opioids during short term administration: effect of age, gender and race. Clin Pharmacol Ther 2003; 74: 102-112
98. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999; 91: 109-118
99. Portenoy RK, Foley KM, Stulman J, et al. Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady state concentrations and the consequences of renal failure. Pain 1991; 47: 13-19
100. Lotsch J, Skarke C, Schmidt H, et al. The transfer half life of morphine-6-glucuronide from plasma to effect site assessed by pupil size measurement in healthy volunteers. Anesthesiology 2001; 95: 1329-1338
101. Skarke C, Jarrar M, Erb K, et al. Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidine. Clin Pharmacol Ther 2003; 74: 303-311
102. Skarke C, Darimont J, Schmidt H, et al. Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clin Pharmacol Ther 2003; 73: 107-121
103. Aubrun F, Monsel S, Langeron O, et al. Post operative titration of intravenous morphine in the elderly patient. Anesthesiology 2002; 96: 17-23
104. Auburn F, Bunge D, Langeron O, et al. Postoperative morphine consumption in the elderly patient. Anesthesiology 2003; 99: 160-165
105. Homburger JA, Meiler SE. Anesthesia drugs, immunity and long term outcome. Curr Opin Anaesthesiol 2006; 19 (4): 423-428
106. Welters I. Opioids and immunosuppression: clinical relevance? Anaesthesist 2003; 52 (5): 442-452
107. Scott JC, Stanski DR. Decreased fentanyl/alfentanil dose requirement with increasing age: a pharmacodynamic basis. J Pharmacol Exp Ther 1987; 240: 159-166
108. Scott JC, Ponganis KV, Stanski DR. EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology 1985; 62: 234-241
109. Minto CF, Schnider TW, Shafer SL. The influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. II: model application. Anesthesiology 1997; 86: 24-33
110. Duvaldestin P, Saada J, Berger JL, et al. Pharmacokinetics, pharmacodynamics and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology 1982; 56: 36-40
111. Edward Morgan G. Clinical anesthesiology. 3rd ed. New York: Lange Medical Books/Mcgraw-Hill Medical Publishing, 2002
112. Kitts JB, Fisher DM, Canfell PC, et al. Pharmacokinetics and pharmacodynamics of atracurium in the elderly. Anesthesiology 1990; 72: 272-275
113. Parker CJ, Hunter JM, Snowdon SL. Effect of age, gender and anaesthetic technique on the pharmacodynamics of atracurium. Br J Anaesth 1993; 70: 38-41
114. Rupp SM, Castagnoli KP, Fisher DM, et al. Pancuronium and vecuronium pharmacokinetics and pharmacodynamics in younger and elderly adults. Anesthesiology 1987; 67: 45-49
115. d'Hollander AA, Massaux F, Nevelsteen M, et al. Age dependent dose-response relationship of ORG NC45 in anaesthetised patients. Br J Anaesth 1982; 54: 653-656
116. Hunter JM. New neuromuscular blocking agents. N Engl J Med 1995; 332 (25): 1691-1699
117. Baykara N, Solak M, Toker K. Predicting recovery from deep neuromuscular block by rocuronium in the elderly. J Clin Anesth 2003; 15: 328-333
118. Bevan DR, Fiset P, Balendran P, et al. Pharmacodynamic behaviour of rocuronium in the elderly. Can J Anesth 1993; 40: 127-132
119. Matteo RS, Ornstein E, Schwartz AE, et al. Pharmacokinetics and pharmacodynamics of rocuronium in elderly surgical patients. Anesth Analg 1993; 77: 1193-1197
120. Shorten GD, Uppington J, Comunale ME. Changes in plasma catecholamine concentrations and haemodynamic effects of rocuronium and vecuronium in elderly patients. Eur J Anaesthesiol 1998; 15 (3): 335-341
121. Cope TM, Hunter JM. Selecting neuromuscular-blocking drugs for elderly patients. DrugsAging 2003; 20 (2): 125-140
122. Maddineni VR, Mirakhur RK, McCoy EP. Plasma cholinesterase activity in elderly and young adults [letter]. Br J Anaesth 1994; 72: 497
123. Viby-Mogensen J. Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme. Anesthesiology 1980; 53: 517-520
124. GlaxoSmithKline UK. Medicine guide for Anectine (suxamethonium chloride) 2008 Oct [online]. Available from URL: http://www.gsk.com/products/prescription- medicines/ anectine.htm [Accessed 2009 Feb 1]
125. Koscielniak-Nielsen ZJ, Law-Min JC, Donati F, et al. Dose-response relations of doxacurim and its reversal with neostigmine in young adults and healthy elderly patients. Anaesth Analg 1992; 74: 845-850
126. Young WL, Matteo RS, Ornstein E. Duration of action of neostigmine and pyridostigmine in the elderly. Anesth Analg 1988; 67: 775-778
127. Young WL, Backus W, Matteo RS, et al. Pharmacokinetics and pharmacodynamics of neostigmine in the elderly [abstract]. Anesthesiology 1984; 61: A300
128. Muravchick S, Owens WD, Felts JA. Glycopyrrolate and cardiac dysrhythmias in geriatric patients after reversal of neuromuscular blockade. Can Anaesth Soc J 1979; 26: 22-25
129. Caldwell JE, Miller RD. Clinical implications of sugammadex. Anaesthesia 2009; 64 Suppl. 1: 66-72
130. Yang LP, Keam SJ. Sugammadex: a review of its use in anaesthetic practice. Drugs 2009; 69 (7): 919-942
131. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesthesia Analg 2007; 104 (3): 575-581
132. Poldermans D, Jeroen JB, Boersma E, et al. Task Force of European Society of Cardiology (endorsed by the European Society of Anaesthesiology). Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009; 30: 2769-2812